{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"8"}],"units":"Participants"}],"description":"Number of participants who reactivated EBV. Patients had their plasma tested once weekly using the TaqMan polymerase chain reaction (PCR) for quantitative determination of EBV-DNA for 6 weeks. Plasma levels \\> 1000 copies per ml plasma were scored as positive.","groups":[{"description":"Visilizumab, Tacrolimus and Methotrexate. All participants.","id":"OG000","title":"First Study Stage: Study Treatment"}],"paramType":"NUMBER","populationDescription":"All participants","reportingStatus":"POSTED","timeFrame":"3 months","title":"Incidence of Epstein-Barr Virus (EBV) Reactivation","type":"SECONDARY","unitOfMeasure":"participants"}